Preclinical research in drug development is done to know impact of a drug on animal and to calculate impact on human. The preclinical contract research organization is known for center offering expertise in research and development that is important for navigating a drug. Also, preclinical CRO delivers skill, knowledge that help to produce pharmaceutical product or medical device from clinical stage to marketing or distribution. 

The Preclinical CRO market is growing due to increase in ability of CROs to offer additional services, increase in R&D expenditure and growing number of competitors that relay on outsourcing for drug development are driving the growth of preclinical CRO market. Moreover, increase in demand for preclinical trials, development in innovative drugs, introduction of complex drug in clinical trials and rise in price of reimbursement policies are contributing to propel the market growth.

Additionally, growing number of life science companies, new competitors are entering into market, focus of companies on research and development that increases demand for outsourcing of preclinical CRO service in the market. However, high labor cost, and lack of standardization to regulatory policies is anticipated to restrain the growth of market.

Segmentation

The Preclinical CRO market segmentation is based on service, end user and region.

Service Outlook

Based on service the preclinical CRO market is segmented into Bioanalysis & DMPK Studies, Toxicology Testing. Toxicology testing is essential in Investigational New Drug (IND)-enabling studies therefore this segment hold maximum market share and due to development of new drug, increases outsourcing of noncore preclinical CRO studies.

End User Outlook

Based on end user the market is segmented Biopharmaceutical Companies, Medical Device Companies. Biopharmaceutical segment hold maximum market share in market and anticipated to grow in coming years owing to increase in outsourcing of service among pharmaceutical companies and due to lack of expertise is expected to propel demand for preclinical CROs.

Regional Outlook

Based on region the preclinical CRO market is categorized into North America, Europe, Asia Pacific, Middle East & Africa, And South America. North America is anticipated to drive the market owing to increase in research and Development activities and developed infrastructure and development of new technologies in medical devices drive the market growth. Also, availability of required resources, and cost of devices play important role in growth of this region. Europe market is anticipated to grow in coming years owing to increasing number of biopharmaceutical companies where outsourcing activities are increased and also have low labor cost that boost the market growth in Europe region.

Market Players

Key leading players in preclinical CRO market include Charles River Laboratories International, Inc., Envigo, Eurofins Scientific., PRA Health Science, Inc., PARAXEL International Corporation; Wuxi AppTec, Laboratory Corporation of America, Inc., Medpace, Inc, ICON plc.

Key Development

November 2019- WuXi AppTec's Lab Testing Division Expands Toxicology Facility in Suzhou, China.

What Does This Report Provide?

This report provides a detailed understanding of the global preclinical CRO market from qualitative and quantitative perspectives during the forecast period. The report also provides dynamic indicators with potential impact on the market during the forecast period and an in-depth analysis of the leading companies operating in the market.

Market Segmentation:

By Service

• Bioanalysis & DMPK Studies
• Toxicology Testing

By End-User

• Biopharmaceutical Companies
• Medical Device Companies

By Region:

• North America Preclinical CRO Market
  • By Country (US, Canada, Mexico)
  • By Service
  • By End User
• Europe Preclinical CRO Market

By Country (Germany, Russia, UK, France, Italy, Spain, Rest of Europe)

• By Service
• By End User

• Asia Pacific Preclinical CRO Market
  • By Country (China, Japan, India, South Korea, Australia, Rest of Asia Pacific)
  • By Service
  • By End User
• Middle East & Africa Preclinical CRO Market
  • By Country (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & AfricServicea)
  • By Service
  • By End-Use
• South America Preclinical CRO Market
  • By Country (Brazil, Argentina, Colombia, Rest of South America)
  • By Service
  • By End-User

Reasons to Buy This Report:

• Market size estimation of thepreclinical CRO market on a regional and global basis
• Unique research Usage for market size estimation and forecast
• Profiling of major companies operating in the market with key developments
• Broad scope to cover all the possible segments helping every stakeholder in the market

Customization:

We provide customization of the study to meet specific requirements:

• By Segment
• By Sub-segment
• By Region/Country

For more information, contact: [email protected]